Curated News
By: NewsRamp Editorial Staff
June 23, 2024

Kadimastem and iTolerance Announce Breakthrough Treatment for Type 1 Diabetes

Reddit Discuss on RedditDiscuss on LinkedIn LinkedInDiscuss on Substack SubstackView History of this news story on GitHub Github
Source News Release

TLDR

  • Kadimastem announces positive results of innovative diabetes treatment, potentially giving them a competitive edge in the field.
  • The treatment combines immune modulator microgel material and insulin-producing islet cells derived from human stem cells, showing effectiveness in restoring normoglycemia.
  • The innovative treatment offers hope for a cure for Type 1 Diabetes without the need for life-long immunosuppression, potentially improving the lives of diabetes patients.
  • The combination therapy reverses diabetes and preserves the functional integrity of the transplanted stem cell-derived islets, marking a significant breakthrough in diabetes research.

Impact - Why it Matters

The announcement of the breakthrough treatment for type 1 diabetes is a significant development in the field of diabetes research and treatment. The innovative approach, recognized by the Diabetes Research Institute at the University of Miami, offers hope for the potential cure of insulin-dependent diabetes without the need for life-long immunosuppression. This has the potential to revolutionize diabetes treatment and improve the quality of life for millions of people worldwide who are living with the disease.

Summary

Kadimastem Ltd. (TASE: KDST) and iTolerance Inc. jointly announced positive results of their leading diabetes product at the 84th scientific conference of the American Diabetes Association. The product, a combination of an immune modulator microgel material and insulin-producing islet cells derived from human stem cells, demonstrated functional insulin release and disease reversal in a model of diabetes. The treatment was recognized by the Diabetes Research Institute at the University of Miami School of Medicine as an innovative approach for the treatment of type 1 diabetes. The study's key findings indicate that this combination therapy reverses diabetes and preserves the functional integrity of the transplanted stem cell-derived islets.

Source Statement

This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Kadimastem and iTolerance Announce Breakthrough Treatment for Type 1 Diabetes

blockchain registration record for the source press release.